Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-05

Clinical Trial Update: Impact of Chromium Supplementation on Glucido-lipidic Metabolism, Oxidative Stress and Inflammatory State in Patients with Gestational Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating chromium supplementation effects on glucose and lipid metabolism, oxidative stress, and inflammatory markers in gest…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chromium supplementation (chromium)

Snippet

Sponsor: University of Kasdi Merbah | Conditions: Gestational Diabetes Mellitus (GDM), Oxidative Stress | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING